An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients

Journal of Mass Spectrometry

Volumn 48, Issue 1, 2013, Pages 105-110

  Seraglia, Roberta ^a   Sartore, Giovanni ^b   Marin, Raffaella ^b   Burlina, Silvia ^b   Manzato, Enzo ^b   Ragazzi, Eugenio ^b   Traldi, Pietro ^a   Lapolla, Annunziata ^b  

^a CNR   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

atherosclerosis; diabetes; HDL; LDL; MALDI MS

Indexed keywords

ANALYTICAL METHOD; APOLIPOPROTEIN A-I (APOA-I); ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; DIABETIC PATIENT; HDL; HIGH-DENSITY LIPOPROTEINS; LDL; LIPID PEROXIDES; LOW DENSITY LIPOPROTEINS; MALDI-MASS SPECTROMETRY; MALDI/MS; RAPID DETERMINATION; SULPHOXIDE;

CHOLESTEROL; DISEASES; LEAD COMPOUNDS; MASS SPECTROMETRY; MEDICAL PROBLEMS; OXIDATION;

AMINO ACIDS;

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LIPID PEROXIDASE; METHIONINE SULFOXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID ANALYSIS; LIPID PEROXIDATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEIN A-I; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; METHIONINE; MIDDLE AGED; OXIDATIVE STRESS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84872298934     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.3113     Document Type: Article

References (19)

1. R. Huxley, F. Barzi, M. Woodward,. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. British Med. J. 2006, 332, 73.
2. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375, 2215.
3. J. A. Beckman, M. A. Creager, P. Libby,. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J. Am. Med. Ass. 2002, 287, 2570.
4. A. Lapolla, S. Porcu, P. Traldi,. Some views on proteomics in diabetes. Clin. Chem. Lab. Med. 2011, 49, 943.
5. P. J. Barter, S. Nicholis, K. A. Rye, G. M. Anantharamaiah, M. Navab, A. M. Fogelman,. Antiinflammatory properties of HDL. Circ. Res. 2004, 95, 764.
6. P. Sangvanich, B. Mackness, S. J. Gaskell, P. Durrington, M. Mackness,. The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein. Biochem. Biophys. Res. Commun. 2003, 300, 501.
7. D. B. Rousselot, P. Therond, J. L. Beaudeux, J. Peynet, A. Le-Grand, J. Delattre,. High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis. Clin. Chem. Lab. Med. 1999, 37, 939.
8. S. Parthasarathy, J. Barnett, L. G. Fong,. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta 1990, 1044, 275.
9. M. Navab, S. Y. Hama, C. J. Cooke, G. M. Anantharamaiah, M. Chaddha, L. Jin, G. Subbanagounder, K. F. Faull, S. T. Reddy, N. E. Miller, A. M. Fogelman,. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J. Lipid Res. 2000, 41, 1481.
10. A. Keys,. Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death. Lancet 1980, 2, 603.
11. B. F. Voight, G. M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, M. K. Jensen, G. Hindy, H. Hõlm, E. L. Ding, T. Johnson, H. Schunkert, N. J. Samani, R. Clarke, J. C. Hopewell, J. F. Thompson, M. Li, G. Thorleifsson, C. Newton-Cheh, K. Musunuru, J. P. Pirruccello, D. Saleheen, L. Chen, A. F. R. Stewart, A. Schillert, U. Thorsteinsdottir, G. Thorgeirsson, S. Anand, J. C. Engert, T. Morgan, J. Spertus, M. Stoll, K. Berger, N. Martinelli, D. Girelli, P. P. McKeown, C. C. Patterson, S. E. Epstein, J. Devaney, M. S. Burnett, V. Mooser, S. Ripatti, I. Surakka, M. S. Nieminen, J. Sinisalo, M. L. Lokki, M. Perola, A. Havulinna, U. de Faire, B. Gigante, E. Ingelsson, T. Zeller, P. Wild, P. I. W. de Bakker, O. H. Klungel, A. H. Maitland-van der Zee, B. J. M. Peters, A. de Boer, D. E. Grobbee, P. W. Kamphuisen, V. H. M. Deneer, C. C. Elbers, N. C. Onland-Moret, M. H. Hofker, C. Wijmenga, W. M. M. Verschuren, J. M. A. Boer, Y. T. van der Schouw, A. Rasheed, P. Frossard, S. Demissie, C. Willer, R. Do, J. M. Ordovas, G. R. Abecasis, M. Boehnke, K. L. Mohlke, M. J. Daly, C. Guiducci, N. P. Burtt, A. Surti, E. Gonzalez, S. Purcell, S. Gabriel, J. Marrugat, J. Peden, J. Erdmann, P. Diemert, C. Willenborg, I. R. König, M. Fischer, C. Hengstenberg, A. Ziegler, I. Buysschaert, D. Lambrechts, F. Van de Werf, K. A. Fox, N. E. El Mokhtari, D. Rubin, J. Schrezenmeir, S. Schreiber, A. Schäfer, J. Danesh, S. Blankenberg, R. Roberts, R. McPherson, H. Watkins, A. S. Hall, K. Overvad, E. Rimm, E. Boerwinkle, A. Tybjaerg-Hansen, L. A. Cupples, M. P. Reilly, O. Melander, P. M. Mannucci, D. Ardissino, D. Siscovick, R. Elosua, K. Stefansson, C. J. O'Donnell, V. Salomaa, D. J. Rader, L. Peltonen, S. M. Schwartz, D. Altshuler, S. Kathiresan,. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomization study. Lancet 2012, 380, 572.
12. A. J. Daugherty, J. L. Dunn, D. L. Rateri, J. W. Heinecke,. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 1994, 94, 437.
13. W. C. Brock, A. J. Jenkins, T. J. Lyons, R. L. Klein, E. Yim, M. Lopez-Virella, R. E. Carter, (DCCT/EDIC) Research Group, S. R. Thorpe, J. W. Baynes,. Increased methionine sulfoxide content of ApoA-I in type 1 diabetes. J. Lipid Res. 2008, 49, 847.
14. N. Rabbani, M. V. Chittari, C. W. Bodmer, D. Zehnder, A. Ceriello, P. J. Thornalley,. Increased glycation and oxidative damage to Apoliprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. Diabetes 2010, 59, 1038.
15. A. Lapolla, E. Manzato, G. Sartore, R. Marin, C. Cosma, A. Bolis, R. Seraglia, P. Traldi,. Evaluation of methionine sulphoxide content of ApoA-I in type 2 diabetic patients and young coronaropathic subjects: a preliminary study. Rapid Commun. Mass Spectrom. 2011, 25, 391-394.
16. R. J. Havel, H. A. Eder, J. H. Bragdon,. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34, 1345.
17. V. N. Schumaker, D. L. Puppione,. Sequential flotation ultracentrifugation. Meth. Enzymol. 1986, 128, 155.
18. Lipid Research Clinics Program. Lipid and lipoprotein analysis. In Manual of Laboratory Operations, 2nd ed, NIH (ed.). US Department of Health and Human Service: Washington, DC, 1982, 63-77.
19. P. Roschlau, E. Bernt, W. Gruber,. Enzymatic determination of total cholesterol in serum. Z. Klin. Chem. Klin. Biochem. 1974, 12, 226.